Evidence map›Paper›PMID 22306690›Full record

ArticleNature immunology2012

Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling.

Michael P Seiler, Rebecca Mathew, Megan K Liszewski, Chauncey J Spooner, Chauncey Spooner, Kenneth Barr, Fanyong Meng, Harinder Singh, Albert Bendelac

Erratum issuedAbstract read
In one paragraph

Article in Nature immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 208 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. MAIT cells: Conserved watchers on the wall.The Journal of experimental medicine · 2025
    Review
  8. Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.Advances in experimental medicine and biology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Markers and makers of NKT17 cells.Experimental & molecular medicine · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. METTL14-dependent mCell reports · 2022
    Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Spooner, Chauncey [corrected to Spooner, Chauncey J]
5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michael P SeilerCommittee on Immunology and The Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois, USA.
Rebecca Mathew
Megan K Liszewski
Chauncey J Spooner
Chauncey Spooner
Kenneth Barr
Fanyong Meng
Harinder Singh
Albert Bendelac
University of Chicago · USHoward Hughes Medical Institute · USGenentech

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
Th1/Th2 Glycolipid AdjuvantsP01AI053725 · NIAID · UNIVERSITY OF CHICAGO · PI TEYTON, LUC · 2003 to 2012
$11.8M
Transcriptional Regulation of Innate-Like T CellsR01AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI ESTERHAZY, DARIA · 1996 to 2025
$7.6M
Transcriptional Regulation of Innate-Like T CellsR37AI038339 · NIAID · UNIVERSITY OF CHICAGO · PI BENDELAC, ALBERT S. · 2017 to 2023
$3.4M
Howard Hughes Medical InstituteNIAID NIH HHS AI038339NIAID NIH HHS AI053725NIAID NIH HHS P01 AI053725NIAID NIH HHS R01 AI038339NIAID NIH HHS R37 AI038339NIAID NIH HHS T32AI0709030NIDDK NIH HHS P30 DK042086NIDDK NIH HHS P30 DK42086
6 · The paper itself

Abstract

Interactions driven by the T cell antigen receptor (TCR) determine the lineage fate of CD4(+)CD8(+) thymocytes, but the molecular mechanisms that induce the lineage-determining transcription factors are unknown. Here we found that TCR-induced transcription factors Egr2 and Egr1 had higher and more-prolonged expression in precursors of the natural killer T (NKT) than in cells of conventional lineages. Chromatin immunoprecipitation followed by deep sequencing showed that Egr2 directly bound and activated the promoter of Zbtb16, which encodes the NKT lineage-specific transcription factor PLZF. Egr2 also bound the promoter of Il2rb, which encodes the interleukin 2 (IL-2) receptor β-chain, and controlled the responsiveness to IL-15, which signals the terminal differentiation of the NKT lineage. Thus, we propose that persistent higher expression of Egr2 specifies the early and late stages of NKT lineage differentiation, providing a discriminating mechanism that enables TCR signaling to 'instruct' a thymic lineage.

Indexed as

Cell DifferentiationCell LineageSignal TransductionAnimalsEarly Growth Response Protein 1Early Growth Response Protein 2HumansKruppel-Like Transcription FactorsMiceMice, KnockoutMolecular Sequence DataNatural Killer T-CellsPromoter Regions, GeneticPromyelocytic Leukemia Zinc Finger ProteinProtein BindingReceptors, Antigen, T-CellEarly Growth Response Protein 1Early Growth Response Protein 2Egr1 protein, mouseEgr2 protein, mouseKruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinReceptors, Antigen, T-CellZbtb16 protein, mouse

Identifiers

PMID22306690
PMCPMC3288314
OpenAlexW2080934862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.